Cargando…
Clinical course and management of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal interstitial lung disease (ILD) with an unpredictable clinical course. Although IPF is rare, healthcare professionals should consider IPF as a potential cause of unexplained chronic dyspnea and/or cough in middle-aged/elderly patients and r...
Autores principales: | Quinn, Caitlin, Wisse, Amy, Manns, Stephenie T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886217/ https://www.ncbi.nlm.nih.gov/pubmed/31827795 http://dx.doi.org/10.1186/s40248-019-0197-0 |
Ejemplares similares
-
Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019) -
Managing comorbidities in idiopathic pulmonary fibrosis
por: Fulton, Blair G, et al.
Publicado: (2015) -
Idiopathic pulmonary fibrosis: pathogenesis and management
por: Sgalla, Giacomo, et al.
Publicado: (2018) -
Advances in the management of idiopathic pulmonary fibrosis
por: Ryu, Jay H, et al.
Publicado: (2010) -
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival
por: Bonham, Catherine A., et al.
Publicado: (2019)